Alexander Kapustin

Company: AstraZeneca

Job title: Associate Principal Scientist

Seminars:

Workshop C – Evaluating the Promise and Challenges of LNP Efficacy and Safety Testing In Vitro 2:30 pm

Huge emphasis is placed on the safety profiles of lipid nanoparticles to mitigate any risk of adverse effects for the patients. Significant promise has been placed on LNPs to become the safest delivery vehicle for drug products leading to significant research into how industry can adequately profile the safety of the LNP drug product. Join…Read more

day: Pre-Conference Day